ARGENX SE 3,125,000 Ordinary Shares (including 1,608,000 American Depositary Shares, each Representing One Ordinary Share) UNDERWRITING AGREEMENTUnderwriting Agreement • February 4th, 2021 • Argenx Se • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 4th, 2021 Company Industry Jurisdiction
Nominal Value £0.001 Each) UNDERWRITING AGREEMENTUnderwriting Agreement • September 14th, 2020 • COMPASS Pathways PLC • Pharmaceutical preparations • New York
Contract Type FiledSeptember 14th, 2020 Company Industry Jurisdiction
OMEROS CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • August 14th, 2020 • Omeros Corp • Pharmaceutical preparations • New York
Contract Type FiledAugust 14th, 2020 Company Industry Jurisdiction
3,676,471 Shares Cardiovascular Systems, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • June 12th, 2020 • Cardiovascular Systems Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledJune 12th, 2020 Company Industry JurisdictionCardiovascular Systems, Inc., a Delaware corporation (the “Company”), proposes to sell 3,676,471 shares (the “Firm Stock”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters named in Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”) an option to purchase up to 551,470 additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
Number of American Depositary Shares] BAVARIAN NORDIC A/S American Depositary Shares, each Representing One-Third of an Ordinary Share (nominal value DKK 10 per share) UNDERWRITING AGREEMENTUnderwriting Agreement • March 8th, 2016 • Bavarian Nordic a/S / ADR • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 8th, 2016 Company Industry Jurisdiction
UNDERWRITING AGREEMENTUnderwriting Agreement • September 23rd, 2014 • Gastar Exploration Inc. • Crude petroleum & natural gas • New York
Contract Type FiledSeptember 23rd, 2014 Company Industry JurisdictionGastar Exploration Inc., a Delaware corporation (the “Company”), proposes to sell 17,000,000 shares (the “Firm Stock”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement (this “Agreement”) an option to purchase up to an aggregate of 2,550,000 additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock.” This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.